Shilpa Pharma, Inc. v. Novartis Pharmaceuticals Corporation

NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
SHILPA PHARMA, INC.,
Appellant
v.
NOVARTIS PHARMACEUTICALS CORPORATION,
Appellee
______________________
2024-1181
______________________
Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in No. IPR2022-
00886.
______________________
JUDGMENT
______________________
MARK BOLAND, Sughrue Mion, PLLC, Washington, DC,
argued for appellant. Also represented by MICHAEL R.
DZWONCZYK, RAJA SALIBA.
WILLIAM M. JAY, Goodwin Procter LLP, Washington,
DC, argued for appellee. Also represented by ELIZABETH A.
KIERNAN, Gibson, Dunn & Crutcher LLP, Dallas, TX; JANE
M. LOVE, ROBERT TRENCHARD, New York, NY.
______________________
Case: 24-1181 Document: 39 Page: 1 Filed: 07/10/2025

-- 1 of 2 --

THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (MOORE, Chief Judge, STOLL, Circuit
Judge, and BUMB, Chief District Judge1).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
July 10, 2025
Date
1 Honorable Renée Marie Bumb, Chief Judge,
United States District Court for the District of New Jersey,
sitting by designation.
Case: 24-1181 Document: 39 Page: 2 Filed: 07/10/2025

-- 2 of 2 --